Prostatic carcinoma: treatment of advanced cases with intravenous diethylstilbestrol diphosphate.
Prostatic carcinoma: treatment of advanced cases with intravenous diethylstilbestrol diphosphate.
复制标题
前列腺癌:静脉注射二磷酸己烯雌酚治疗晚期病例。
DOI:
10.1016/s0022-5347(17)67313-0
复制
发表时间:
1955
期刊:
影响因子:
--
通讯作者:
L. Prendergast
中科院分区:
文献类型:
--
作者:
R. Flocks;H. Marberger;B. Begley;L. Prendergast
METHODSixty-six patients with proven prostatic carcinoma have been given this compound. Thirty-four of these had failed to respond or had become refractory to the usual estrogens. Twelve advanced cases had had no previous hormonal therapy. In twenty with less advanced disease, this drug was used as an adjunct to other therapy.Diethylstilbestrol diphosphate was administered in doses ranging from 250 mg. to 1250 mg.(ampules contained 250 mg. in 5 ml. diluent), average dose being 500 mg., given in an intravenous infusion of isotonic saline or dextrose 5 per cent in water, the total volume of which ranged from 200 to 500 ml. The rate of administration averaged 300 ml. per hour, and generally one, or perhaps two, infusions were given daily. A course of therapy ranged from the common of 5 days to the exceptional of 20 days, depending upon the rapidity of the clinical response. Repeated courses were given usually at monthly intervals. Number of courses of therapy varied from one to eleven, twelve of the patients having had four or more courses. Thirty-eight of the total patients had only a single course; the highest total dose in a given patient was 31,500 mg.